Abnormally active or overexpression of EZH2 can lead to changes in gene expression patterns and promote tumor growth and spread and immune evasion through various mechanisms, including suppressing antigen presentation, affecting the migration of immune cells, and enhancing the inhibitory activity of cluster of differentiation (CD) 4 +T regulatory cells. Here, EZH2 is linked to neoplasm.